Quote:

---

Did we get an update on UK trial progress? I missed a few portions of the call, but was really hoping for news on this.

---

Still no enrollment, with Dr.NP stating there has been some back-and-forth regarding protocol adjustments. And this is in the context of him telling us that we were all set to enroll on at least two different occasions. This type of inconsistent messaging will not be appreciated nor tolerated by institutional investors.